{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:54:47Z","timestamp":1792634087094,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T00:00:00Z","timestamp":1474416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T00:00:00Z","timestamp":1474416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>IL-18BP is a natural antagonist of pro-inflammatory IL-18 cytokine linked to autoimmune disorders like rheumatoid arthritis. However, its role in post menopausal osteoporosis is still unknown. In this study, we investigated the role of IL-18BP on murine osteoblasts, its effect on osteoblasts-CD4+ T cells and osteoblasts-CD11b+ macrophage co-culture. mIL-18BPd enhances osteoblast differentiation and inhibits the activation of NLRP3 inflammasome and caspase-1 which process IL-18 to its active form. Using estrogen deficient mice, we also determined the effect of mIL-18BP on various immune and skeletal parameters. Ovariectomized mice treated with mIL-18BPd exhibited decrease in Th17\/Treg ratio and pro-inflammatory cytokines. mIL-18BPd treatment restored trabecular microarchitecture, preserved cortical bone parameters likely attributed to an increased number of bone lining cells and reduced osteoclastogenesis. Importantly, these results were corroborated in female osteoporotic subjects where decreased serum IL-18BP levels and enhanced serum IL-18 levels were observed. Our study forms a strong basis for using humanized IL-18BP towards the treatment of postmenopausal osteoporosis.<\/jats:p>","DOI":"10.1038\/srep33680","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T08:40:16Z","timestamp":1474447216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["IL-18BP is decreased in osteoporotic women: Prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation"],"prefix":"10.1038","volume":"6","author":[{"given":"Mohd Nizam","family":"Mansoori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Kakaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul M","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Kureel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,21]]},"reference":[{"key":"BFsrep33680_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.0105-2896.2005.00334.x","volume":"208","author":"JA Clowes","year":"2005","unstructured":"Clowes, J. A., Riggs, B. L. & Khosla, S. The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 208, 207\u2013227 (2005).","journal-title":"Immunol Rev"},{"key":"BFsrep33680_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/jn\/131.3.723","volume":"131","author":"C Picherit","year":"2001","unstructured":"Picherit, C. et al. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131, 723\u2013728 (2001).","journal-title":"J Nutr"},{"key":"BFsrep33680_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1677\/JOE-08-0568","volume":"201","author":"R Hardy","year":"2009","unstructured":"Hardy, R. & Cooper, M. S. Bone loss in inflammatory disorders. J Endocrinol 201, 309\u2013320 (2009).","journal-title":"J Endocrinol"},{"key":"BFsrep33680_CR4","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1538::AID-CNCR3>3.0.CO;2-G","volume":"80","author":"JA Kanis","year":"1997","unstructured":"Kanis, J. A. & McCloskey, E. V. Bone turnover and biochemical markers in malignancy. Cancer 80, 1538\u20131545 (1997).","journal-title":"Cancer"},{"key":"BFsrep33680_CR5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.clinbiochem.2012.03.021","volume":"45","author":"J Kular","year":"2012","unstructured":"Kular, J., Tickner, J., Chim, S. M. & Xu, J. An overview of the regulation of bone remodelling at the cellular level. Clin Biochem 45, 863\u2013873 (2012).","journal-title":"Clin Biochem"},{"key":"BFsrep33680_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.abb.2014.07.034","volume":"561C","author":"KB Paiva","year":"2014","unstructured":"Paiva, K. B. & Granjeiro, J. M. Bone tissue remodeling and development: Focus on matrix metalloproteinase functions. Arch Biochem Biophys 561C, 74\u201387 (2014).","journal-title":"Arch Biochem Biophys"},{"key":"BFsrep33680_CR7","doi-asserted-by":"publisher","first-page":"720504","DOI":"10.1155\/2013\/720504","volume":"2013","author":"G Mori","year":"2013","unstructured":"Mori, G., D\u2019Amelio, P., Faccio, R. & Brunetti, G. The Interplay between the bone and the immune system. Clin Dev Immunol 2013, 720504 (2013).","journal-title":"Clin Dev Immunol"},{"key":"BFsrep33680_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.11613\/BM.2013.007","volume":"23","author":"J Zupan","year":"2013","unstructured":"Zupan, J., Jeras, M. & Marc, J. Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem Med (Zagreb) 23, 43\u201363 (2013).","journal-title":"Biochem Med (Zagreb)"},{"key":"BFsrep33680_CR9","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1172\/JCI117606","volume":"94","author":"R Kitazawa","year":"1994","unstructured":"Kitazawa, R., Kimble, R. B., Vannice, J. L., Kung, V. T. & Pacifici, R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94, 2397\u20132406 (1994).","journal-title":"J Clin Invest"},{"key":"BFsrep33680_CR10","doi-asserted-by":"publisher","first-page":"e44552","DOI":"10.1371\/journal.pone.0044552","volume":"7","author":"AM Tyagi","year":"2012","unstructured":"Tyagi, A. M. et al. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. Plos One 7, e44552 (2012).","journal-title":"Plos One"},{"key":"BFsrep33680_CR11","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1359\/jbmr.1997.12.6.935","volume":"12","author":"RB Kimble","year":"1997","unstructured":"Kimble, R. B., Bain, S. & Pacifici, R. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12, 935\u2013941 (1997).","journal-title":"J Bone Miner Res"},{"key":"BFsrep33680_CR12","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.4049\/jimmunol.1101408","volume":"187","author":"C Conforti-Andreoni","year":"2011","unstructured":"Conforti-Andreoni, C. et al. Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18. J Immunol 187, 5842\u20135850 (2011).","journal-title":"J Immunol"},{"key":"BFsrep33680_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1189\/jlb.1012543","volume":"93","author":"KH Mills","year":"2013","unstructured":"Mills, K. H., Dungan, L. S., Jones, S. A. & Harris, J. The role of inflammasome-derived IL-1 in driving IL-17 responses. J Leukoc Biol 93, 489\u2013497 (2013).","journal-title":"J Leukoc Biol"},{"key":"BFsrep33680_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","volume":"19","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi, K., Yoshimoto, T., Tsutsui, H. & Okamura, H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19, 423\u2013474 (2001).","journal-title":"Annu Rev Immunol"},{"key":"BFsrep33680_CR15","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.4049\/jimmunol.170.4.2100","volume":"170","author":"NK Banda","year":"2003","unstructured":"Banda, N. K. et al. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J Immunol 170, 2100\u20132105 (2003).","journal-title":"J Immunol"},{"key":"BFsrep33680_CR16","first-page":"289","volume":"4","author":"CA Dinarello","year":"2013","unstructured":"Dinarello, C. A., Novick, D., Kim, S. & Kaplanski, G. Interleukin-18 and IL-18 binding protein. Front Immunol 4, 289 (2013).","journal-title":"Front Immunol"},{"key":"BFsrep33680_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10753-012-9524-8","volume":"36","author":"W Zhang","year":"2013","unstructured":"Zhang, W. et al. IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. Inflammation 36, 103\u2013109 (2013).","journal-title":"Inflammation"},{"key":"BFsrep33680_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1517\/14728222.7.6.701","volume":"7","author":"K Matsui","year":"2003","unstructured":"Matsui, K., Tsutsui, H. & Nakanishi, K. Pathophysiological roles for IL-18 in inflammatory arthritis. Expert Opin Ther Targets 7, 701\u2013724 (2003).","journal-title":"Expert Opin Ther Targets"},{"key":"BFsrep33680_CR19","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1172\/JCI7317","volume":"104","author":"JA Gracie","year":"1999","unstructured":"Gracie, J. A. et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104, 1393\u20131401 (1999).","journal-title":"J Clin Invest"},{"key":"BFsrep33680_CR20","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1158\/1078-0432.CCR-13-0568","volume":"19","author":"G Carbotti","year":"2013","unstructured":"Carbotti, G. et al. The IL-18 antagonist IL-18-binding protein is produced in the human ovarian cancer microenvironment. Clinical cancer research: an official journal of the American Association for Cancer Research 19, 4611\u20134620, 10.1158\/1078-0432.CCR-13-0568 (2013).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"BFsrep33680_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/hyb.2010.0058","volume":"29","author":"S Lee","year":"2010","unstructured":"Lee, S. et al. Development of isoform-specific monoclonal antibodies against human IL-18 binding protein. Hybridoma (Larchmt) 29, 517\u2013524 (2010).","journal-title":"Hybridoma (Larchmt)"},{"key":"BFsrep33680_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ncprheum0020","volume":"1","author":"IB McInnes","year":"2005","unstructured":"McInnes, I. B. & Liew, F. Y. Cytokine networks\u2013towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol 1, 31\u201339 (2005).","journal-title":"Nat Clin Pract Rheumatol"},{"key":"BFsrep33680_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF03191127","volume":"31","author":"PP Tak","year":"2006","unstructured":"Tak, P. P., Bacchi, M. & Bertolino, M. Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis. Eur J Drug Metab Pharmacokinet 31, 109\u2013116 (2006).","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"BFsrep33680_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/eje.0.1460389","volume":"146","author":"C Kristo","year":"2002","unstructured":"Kristo, C. et al. Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing\u2019s syndrome. Eur J Endocrinol 146, 389\u2013395 (2002).","journal-title":"Eur J Endocrinol"},{"key":"BFsrep33680_CR25","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1111\/bph.13138","volume":"172","author":"L Zhu","year":"2015","unstructured":"Zhu, L. et al. Activation of NALP1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis. British journal of pharmacology 172, 3446\u20133459, 10.1111\/bph.13138 (2015).","journal-title":"British journal of pharmacology"},{"key":"BFsrep33680_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.celrep.2011.11.005","volume":"1","author":"YH Youm","year":"2012","unstructured":"Youm, Y. H. et al. The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. Cell reports 1, 56\u201368, 10.1016\/j.celrep.2011.11.005 (2012).","journal-title":"Cell reports"},{"key":"BFsrep33680_CR27","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00198-011-1650-x","volume":"23","author":"AM Tyagi","year":"2012","unstructured":"Tyagi, A. M. et al. Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss. Osteoporos Int 23, 1151\u20131161 (2012).","journal-title":"Osteoporos Int"},{"key":"BFsrep33680_CR28","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.4049\/jimmunol.0902477","volume":"183","author":"H Kumar","year":"2009","unstructured":"Kumar, H. et al. Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan. Journal of immunology 183, 8061\u20138067, 10.4049\/jimmunol.0902477 (2009).","journal-title":"Journal of immunology"},{"key":"BFsrep33680_CR29","doi-asserted-by":"publisher","first-page":"e21216","DOI":"10.1371\/journal.pone.0021216","volume":"6","author":"AM Tyagi","year":"2011","unstructured":"Tyagi, A. M. et al. Daidzein prevents the increase in CD4+\u2009CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. Plos One 6, e21216 (2011).","journal-title":"Plos One"},{"key":"BFsrep33680_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","volume":"29","author":"XO Yang","year":"2008","unstructured":"Yang, X. O. et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44\u201356 (2008).","journal-title":"Immunity"},{"key":"BFsrep33680_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nri2295","volume":"8","author":"C Dong","year":"2008","unstructured":"Dong, C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8, 337\u2013348 (2008).","journal-title":"Nat Rev Immunol"},{"key":"BFsrep33680_CR32","doi-asserted-by":"publisher","first-page":"8280","DOI":"10.4049\/jimmunol.175.12.8280","volume":"175","author":"JK Yoo","year":"2005","unstructured":"Yoo, J. K. et al. IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase\/Akt and MEK\/ERK1\/2 pathways. J Immunol 175, 8280\u20138286 (2005).","journal-title":"J Immunol"},{"key":"BFsrep33680_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-4933-2-14","volume":"2","author":"L Ginaldi","year":"2005","unstructured":"Ginaldi, L., Di Benedetto, M. C. & De Martinis, M. Osteoporosis, inflammation and ageing. Immun Ageing 2, 14 (2005).","journal-title":"Immun Ageing"},{"key":"BFsrep33680_CR34","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1210\/endo.136.8.7628403","volume":"136","author":"H Dobnig","year":"1995","unstructured":"Dobnig, H. & Turner, R. T. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136, 3632\u20133638 (1995).","journal-title":"Endocrinology"},{"key":"BFsrep33680_CR35","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.bone.2006.11.027","volume":"40","author":"LV Hale","year":"2007","unstructured":"Hale, L. V. et al. PINP: a serum biomarker of bone formation in the rat. Bone 40, 1103\u20131109 (2007).","journal-title":"Bone"},{"key":"BFsrep33680_CR36","doi-asserted-by":"publisher","first-page":"165742","DOI":"10.1155\/2014\/165742","volume":"2014","author":"Q Ji","year":"2014","unstructured":"Ji, Q. et al. Elevated plasma IL-37, IL-18 and IL-18BP concentrations in patients with acute coronary syndrome. Mediators of inflammation 2014, 165742, 10.1155\/2014\/165742 (2014).","journal-title":"Mediators of inflammation"},{"key":"BFsrep33680_CR37","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gut.50.6.812","volume":"50","author":"PV Sivakumar","year":"2002","unstructured":"Sivakumar, P. V. et al. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50, 812\u2013820 (2002).","journal-title":"Gut"},{"key":"BFsrep33680_CR38","doi-asserted-by":"publisher","first-page":"447S","DOI":"10.1093\/ajcn\/83.2.447S","volume":"83","author":"CA Dinarello","year":"2006","unstructured":"Dinarello, C. A. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 83, 447S\u2013455S (2006).","journal-title":"Am J Clin Nutr"},{"key":"BFsrep33680_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1006\/bbrc.2001.4380","volume":"281","author":"C Makiishi-Shimobayashi","year":"2001","unstructured":"Makiishi-Shimobayashi, C. et al. Interleukin-18 up-regulates osteoprotegerin expression in stromal\/osteoblastic cells. Biochem Biophys Res Commun 281, 361\u2013366 (2001).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep33680_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.archoralbio.2013.11.006","volume":"59","author":"X Zhong","year":"2014","unstructured":"Zhong, X., Wang, H. & Huang, S. Endothelin-1 induces interleukin-18 expression in human osteoblasts. Arch Oral Biol 59, 289\u2013296 (2014).","journal-title":"Arch Oral Biol"},{"key":"BFsrep33680_CR41","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1084\/jem.185.6.1005","volume":"185","author":"N Udagawa","year":"1997","unstructured":"Udagawa, N. et al. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte\/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 185, 1005\u20131012 (1997).","journal-title":"J Exp Med"},{"key":"BFsrep33680_CR42","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1136\/ard.2003.018481","volume":"63","author":"SM Dai","year":"2004","unstructured":"Dai, S. M., Nishioka, K. & Yudoh, K. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Ann Rheum Dis 63, 1379\u20131386 (2004).","journal-title":"Ann Rheum Dis"},{"key":"BFsrep33680_CR43","doi-asserted-by":"publisher","first-page":"e35979","DOI":"10.1371\/journal.pone.0035979","volume":"7","author":"SL Bonar","year":"2012","unstructured":"Bonar, S. L. et al. Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PloS one 7, e35979, 10.1371\/journal.pone.0035979 (2012).","journal-title":"PloS one"},{"key":"BFsrep33680_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1262\/jrd.17029","volume":"51","author":"Y Murakami","year":"2005","unstructured":"Murakami, Y., Otsuki, M., Kusumoto, K., Takeuchi, S. & Takahashi, S. Estrogen inhibits interleukin-18 mRNA expression in the mouse uterus. The Journal of reproduction and development 51, 639\u2013647 (2005).","journal-title":"The Journal of reproduction and development"},{"key":"BFsrep33680_CR45","doi-asserted-by":"crossref","unstructured":"Xu, Y. et al. NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice. Brain, behavior and immunity, 10.1016\/j.bbi.2016.02.022 (2016).","DOI":"10.1016\/j.bbi.2016.02.022"},{"key":"BFsrep33680_CR46","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1002\/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P","volume":"30","author":"MG Netea","year":"2000","unstructured":"Netea, M. G., Kullberg, B. J. & Verschueren, I. & Van Der Meer, J. W. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. European journal of immunology 30, 3057\u20133060, 10.1002\/1521-4141(200010)30:10&lt;3057::AID-IMMU3057&gt;3.0.CO;2-P (2000).","journal-title":"European journal of immunology"},{"key":"BFsrep33680_CR47","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/eji.201041226","volume":"41","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk, F. L. et al. The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. European journal of immunology 41, 2260\u20132268, 10.1002\/eji.201041226 (2011).","journal-title":"European journal of immunology"},{"key":"BFsrep33680_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","volume":"22","author":"BC Silva","year":"2015","unstructured":"Silva, B. C. & Bilezikian, J. P. Parathyroid hormone: anabolic and catabolic actions on the skeleton. Current opinion in pharmacology 22, 41\u201350, 10.1016\/j.coph.2015.03.005 (2015).","journal-title":"Current opinion in pharmacology"},{"key":"BFsrep33680_CR49","doi-asserted-by":"crossref","unstructured":"Tyagi, A. M. et al. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-alpha antibodies. J Bone Miner Res 29 (2014).","DOI":"10.1002\/jbmr.2228"},{"key":"BFsrep33680_CR50","doi-asserted-by":"crossref","unstructured":"Mansoori, Mohd N. et al. \u201cMethoxyisoflavones formononetin and isoformononetin inhibit the differentiation of Th17 cells and B-cell lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions\u201d. Menopause 23.5, 565\u2013576 (2016).","DOI":"10.1097\/GME.0000000000000646"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep33680","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T23:27:20Z","timestamp":1672874840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep33680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,21]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,14]]}},"alternative-id":["BFsrep33680"],"URL":"https:\/\/doi.org\/10.1038\/srep33680","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,21]]},"assertion":[{"value":"18 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33680"}}